Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity

Journal of Natural Products

Volumn 71, Issue 4, 2008, Pages 713-715

  Nam, Hee Yoo ^a   Dae, Sik Jang ^a   Jeong, Lim Yoo ^a   Yun, Mi Lee ^a   Young, Sook Kim ^a   Cho, Jung Hee ^b   Jin, Sook Kim ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ERIGEROFLAVANONE; FLAVANONE DERIVATIVE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ASSAY; DRUG INHIBITION; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; ERIGERON; ERIGERON ANNUUS; FLOWER; IN VITRO STUDY; NONHUMAN; PROTEIN GLYCOSYLATION; RAT; STRUCTURE ANALYSIS;

ALDEHYDE REDUCTASE; ANIMALS; ERIGERON; FLAVANONES; FLOWERS; GLYCOSYLATION END PRODUCTS, ADVANCED; KOREA; LENS, CRYSTALLINE; MOLECULAR STRUCTURE; PLANTS, MEDICINAL; RATS;

ERIGERON ANNUUS; RATTUS;

EID: 43249086213     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np070489a     Document Type: Article

References (22)

1. Nesom, G. L. Phytologia 1989, 66, 118-138.
2. Jiangsu College of New Medicine. A Dictionary of the Traditional Chinese Medicines; Peoples' Hygiene Publisher: Beijing, 1977; p 4.
3. Li, X.; Pan, J.; Gao, K. Pharmazie 2006, 61, 474-477.
4. Oh, H.; Lee, S.; Lee, H.-S.; Lee, D.-H.; Lee, S. Y.; Chung, H.-T.; Kim, T. S.; Kwon, T.-O. Phytochemistry 2002, 61, 175-179.
5. Hashidoko, Y. Biosci. Biotech. Biochem. 1995, 59, 886-890.
6. Iijima, T.; Yaoita, Y.; Kikuchi, M. Chem. Pharm. Bull. 2003, 51, 894-896.
7. Li, X.; Yang, M.; Han, Y.-F.; Gao, K. Planta Med. 2005, 71, 268-272.
8. Iijima, T.; Yaoita, Y.; Kikuchi, M. Chem. Pharm. Bull. 2003, 51, 545-549.
9. Lee, G. Y.; Jang, D. S.; Lee, Y. M.; Kim, J. M.; Kim, J. S. Arch. Pharm. Res. 2006, 29, 587-590.
10. Jang, D. S.; Kim, J. M.; Lee, Y. M.; Kim, Y. S.; Kim, J.-H.; Kim, J. S. Chem. Pharm. Bull. 2006, 54, 1315-1317.
11. Forbes, J. M.; Cooper, M. E.; Oldfield, M. D.; Thomas, M. C. J. Am. Soc. Nephrol. 2003, S254-S258.
12. Yabe-Nishimura, C. Pharmacol. Rev. 1998, 50, 21-33.
13. Han, X. H.; Hong, S. S.; Hwang, J. S.; Lee, M. K.; Hwang, B. Y.; Ro, J. S. Arch. Pharm. Res. 2007, 30, 13-17.
14. Mustafa, K.; Perry, N. B.; Weavers, R. T. Phytochemistry 2003, 64, 1285-1293.
15. Aitken, R. A.; Bibby, M. C.; Cooper, P. A.; Double, J. A.; Laws, A. L.; Ritchie, R. B.; Wilson, D. W. J. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 181-188.
16. Valenti, P.; Fabbri, G.; Rampa, A.; Bisi, A.; Gobbi, S.; Da Re, P.; Carrara, M.; Sgevano, A.; Cima, L. Anti-Cancer Drug Des. 1996, 11, 243-252.
17. Lee, M. H.; Son, Y. K.; Han, Y. N. Arch. Pharm. Res. 2002, 25, 842-850.
18. Do, J. C.; Yu, Y. J.; Jung, K. Y.; Son, K. H. Kor. J. Pharmacogn. 1992, 23, 9-13.
19. Matsuda, H.; Wang, T.; Managi, H.; Yoshikawa, M. Bioorg. Med. Chem. 2003, 11, 5317-5323.
20. Kawanishi, K.; Ueda, H.; Moriyasu, M. Curr. Med. Chem. 2003, 10, 1353-1374.
21. Matsuda, H.; Morikawa, T.; Toguchida, I.; Yoshikawa, M. Chem. Pharm. Bull. 2002, 50, 788-795.
22. Jang, D. S.; Yoo, N. H.; Kim, J. M.; Lee, Y. M.; Yoo, J. L.; Kim, Y. S.; Kim, J. S. Nat. Prod. Sci. 2007, 13, 160-163.